Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical…
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide!-->…
Weiterlesen...
Weiterlesen...